SILVERCREST ASSET MANAGEMENT GROUP LLC - PACIRA PHARMACEUTICALS INC ownership

PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 297 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 9.12 and the average weighting 0.2%.

Quarter-by-quarter ownership
SILVERCREST ASSET MANAGEMENT GROUP LLC ownership history of PACIRA PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$4,922,760
+15.7%
122,854
+17.8%
0.04%
+9.4%
Q1 2023$4,254,769
+5.6%
104,258
-0.1%
0.03%
+3.2%
Q4 2022$4,029,764
-72.5%
104,371
-62.1%
0.03%
-74.4%
Q3 2022$14,651,000
-13.4%
275,451
-5.1%
0.12%
-6.2%
Q2 2022$16,925,000
-25.6%
290,310
-2.7%
0.13%
-12.8%
Q1 2022$22,761,000
+6.7%
298,236
-15.9%
0.15%
+9.6%
Q4 2021$21,337,000
+38.0%
354,606
+28.5%
0.14%
+29.8%
Q3 2021$15,459,000
-12.9%
276,047
-5.6%
0.10%
-10.3%
Q2 2021$17,752,000
-19.0%
292,556
-6.5%
0.12%
-21.6%
Q1 2021$21,927,000
-13.0%
312,844
-25.7%
0.15%
-19.6%
Q4 2020$25,191,000
+4.9%
420,967
+5.4%
0.18%
-10.7%
Q3 2020$24,007,000
+130.5%
399,319
+101.2%
0.21%
+123.9%
Q2 2020$10,413,000
+53.8%
198,448
-1.7%
0.09%
+26.0%
Q1 2020$6,772,000
-15.6%
201,981
+14.0%
0.07%
+17.7%
Q4 2019$8,027,000
+14.1%
177,198
-4.1%
0.06%
+6.9%
Q3 2019$7,032,000184,7200.06%
Other shareholders
PACIRA PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Prosight Management, LP 1,210,377$37,134,36611.77%
Gagnon Advisors, LLC 180,331$5,532,5554.63%
GAGNON SECURITIES LLC 565,429$17,347,3614.35%
ARDSLEY ADVISORY PARTNERS LP 310,000$9,510,8002.12%
RICE HALL JAMES & ASSOCIATES, LLC 968,485$29,713,1201.89%
AlphaCentric Advisors LLC 103,000$3,160,0401.79%
1492 Capital Management LLC 79,687$2,444,7971.58%
ARDSLEY ADVISORY PARTNERS LP 149,000$4,571,3201.02%
OUTFITTER FINANCIAL LLC 32,305$991,1170.93%
Rock Springs Capital Management LP 1,055,500$32,382,7400.87%
View complete list of PACIRA PHARMACEUTICALS INC shareholders